How long do you need to take neratinib/neratinib?

Neratinib/ As a drug with high anti-cancer activity, Neratinib is suitable for long-term adjuvant treatment of HER2-positive early breast cancer, or in combination with other drugs such as trastuzumab, capecitabine and paclitaxel for the treatment of advanced HER2-positive breast cancer. However, when using neratinib, you also need to be alert to its possible side effects and use it rationally under the guidance of a doctor. Neratinib is a targeted therapy drug. According to the instruction guide, the recommended dose is 240 mg (6 tablets) once a day with food.

For early stageHer-2-positive breast cancer, give it once a day for one year, unless your breast cancer comes back, that is, you experience unacceptable toxicity or disease progression. For advanced or metastatic breast cancer, it may be given daily in a 21-day cycle (capecitabine is given on days 1-14 of the cycle) as long as the patient benefits from the drug (for example, the cancer does not worsen while taking neratinib) and the patient tolerates the drug without unacceptable side effects.

Neratinib may cause some side effects, such as diarrhea, nausea, vomiting, fatigue, etc. If the patient develops neratinib toxicity (such as severe diarrhea or liver toxicity), the dose may be temporarily stopped until the patient recovers and then restarted at a lower dose, or if the toxicity is too severe, neratinib may be discontinued completely.

Therefore, during the use of neratinib, patients should closely cooperate with doctors for monitoring and follow-up. Doctors regularly perform physical examinations, laboratory tests, and imaging studies on patients to evaluate the progression of the disease and the effectiveness of medications. These examinations are necessary and can help doctors adjust treatment plans in a timely manner.